Literature DB >> 18093563

The medical management of the epilepsies in children: conceptual and practical considerations.

Miquel Raspall-Chaure1, Brian G Neville, Rod C Scott.   

Abstract

Epilepsy in children encompasses several syndromes. The cardinal feature of these syndromes is a predisposition to epileptic seizures but each is associated with different prognoses. The goals of treatment will clearly differ between children who become seizure-free on antiepileptic drug (AED) treatment and those children with refractory epilepsy. Treatment should be tailored to the needs of the patient, with a comprehensive approach that addresses the common additional morbidities in children with epilepsy. In this Review, we present an overview of the medical management of epilepsy in children and discuss the dilemmas of everyday practice, such as selection of AED, assessment of outcome, monitoring of treatment, and the decision to withdraw medication when the child is free from seizures. Furthermore, we emphasise the need to establish rational goals for treatment, such as aiming for the best possible quality of life rather than freedom from seizures at all costs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18093563     DOI: 10.1016/S1474-4422(07)70324-1

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  12 in total

1.  Intravenous methylprednisolone pulse therapy for children with epileptic encephalopathy.

Authors:  Maria Carmela Pera; Giovanna Randazzo; Silvia Masnada; Serena Donetti Dontin; Valentina De Giorgis; Umberto Balottin; Pierangelo Veggiotti
Journal:  Funct Neurol       Date:  2015 Jul-Sep

2.  Attention deficit hyperactivity disorder (ADHD) in children with epilepsy.

Authors:  Man Wang; Qin Zhao; Huicong Kang; Suiqiang Zhu
Journal:  Ir J Med Sci       Date:  2019-06-11       Impact factor: 1.568

3.  Standard dose valproic acid does not cause additional cognitive impact in a rodent model of intractable epilepsy.

Authors:  Adam P Jellett; Kyle Jenks; Marcella Lucas; Rod C Scott
Journal:  Epilepsy Res       Date:  2014-11-21       Impact factor: 3.045

Review 4.  The long-term safety of antiepileptic drugs.

Authors:  Athanasios Gaitatzis; Josemir W Sander
Journal:  CNS Drugs       Date:  2013-06       Impact factor: 5.749

Review 5.  Mechanisms Responsible for Cognitive Impairment in Epilepsy.

Authors:  Pierre-Pascal Lenck-Santini; Rodney C Scott
Journal:  Cold Spring Harb Perspect Med       Date:  2015-09-03       Impact factor: 6.915

Review 6.  Refractory epilepsy in children.

Authors:  Satinder Aneja; Puneet Jain
Journal:  Indian J Pediatr       Date:  2014-08-09       Impact factor: 1.967

7.  Possible association between moderate intellectual disability and weight gain in valproic acid-treated patients with epilepsy.

Authors:  Yukiko Tanamachi; Junji Saruwatari; Madoka Noai; Ryoko Kamihashi; Hiromi Soraoka; Yuki Yoshimori; Naoki Ogusu; Kentaro Oniki; Norio Yasui-Furukori; Takateru Ishitsu; Kazuko Nakagawa
Journal:  Neuropsychiatr Dis Treat       Date:  2015-04-07       Impact factor: 2.570

Review 8.  Network science for the identification of novel therapeutic targets in epilepsy.

Authors:  Rod C Scott
Journal:  F1000Res       Date:  2016-05-16

9.  Prevalence of childhood and adolescence epilepsy in Upper Egypt (desert areas).

Authors:  Wafaa M Farghaly; Mohamed A Abd Elhamed; Enas M Hassan; Wael T Soliman; Mohamed A Yhia; Nermin A Hamdy
Journal:  Egypt J Neurol Psychiatr Neurosurg       Date:  2018-11-09

Review 10.  Methylphenidate for attention problems in epilepsy patients: Safety and efficacy.

Authors:  Beth A Leeman-Markowski; Jesse Adams; Samantha P Martin; Orrin Devinsky; Kimford J Meador
Journal:  Epilepsy Behav       Date:  2020-12-24       Impact factor: 2.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.